The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dalton Mark F since year 2005.
The trader's CIK number is 1250267.
At the time of this reporting, Dalton Mark F is the Director of Progenics Pharmaceuticals Inc .
(stock ticker symbol PGNX).
See this page for all insider trading activities at Progenics Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2008-05-14||PGNX||Progenics Pharmaceuticals Inc||Option Ex||7,500||5.36||40,222|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dalton Mark F (Director of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.